Review




Structured Review

Optimus Corp cross validation
Cross Validation, supplied by Optimus Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pm42105763-984-24-17?v=Optimus+Corp
Average 86 stars, based on 1 article reviews
cross validation - by Bioz Stars, 2026-07
86/100 stars

Images



Similar Products

93
Genovis Inc cross validation
Cross Validation, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/med_rxiv__2025__10__27__25338754-71-24-30?v=Genovis+Inc
Average 93 stars, based on 1 article reviews
cross validation - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

86
Adata Software cross validation folds
Cross Validation Folds, supplied by Adata Software, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/bio_rxiv__64898__2026__05__30__728980-540-16-18?v=Adata+Software
Average 86 stars, based on 1 article reviews
cross validation folds - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Wolters Kluwer Health cross validation
Cross Validation, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pm42235954-88-21-2?v=Wolters+Kluwer+Health
Average 86 stars, based on 1 article reviews
cross validation - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Optimus Corp cross validation
Cross Validation, supplied by Optimus Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pm42105763-984-24-17?v=Optimus+Corp
Average 86 stars, based on 1 article reviews
cross validation - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Kaggle Inc cross validation
Cross Validation, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pmc13040023-181-7-2?v=Kaggle+Inc
Average 86 stars, based on 1 article reviews
cross validation - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Umetrics cross validation tool simca p software
Cross Validation Tool Simca P Software, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pm41825490-109-3-9?v=Umetrics
Average 86 stars, based on 1 article reviews
cross validation tool simca p software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Boehringer Ingelheim ada assay cross validation
Ada Assay Cross Validation, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pm41667701-179-5-10?v=Boehringer+Ingelheim
Average 86 stars, based on 1 article reviews
ada assay cross validation - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Sanofi cross pathway validation with sar408701
The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; <t>SAR408701:</t> Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.
Cross Pathway Validation With Sar408701, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/med_rxiv__64898__2026__01__30__26345218-187-1-19?v=Sanofi
Average 86 stars, based on 1 article reviews
cross pathway validation with sar408701 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

93
Genovis Inc selection operator with cross validation
The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; <t>SAR408701:</t> Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.
Selection Operator With Cross Validation, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cross+validation/pm41087962-19-15-16?v=Genovis+Inc
Average 93 stars, based on 1 article reviews
selection operator with cross validation - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; SAR408701: Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.

Journal: medRxiv

Article Title: Translational PBPK-QSP modeling platform for antibody-drug conjugates (ADC): within-target and cross-pathway validation to bridge preclinical and clinical results

doi: 10.64898/2026.01.30.26345218

Figure Lengend Snippet: The procedures for within-target validation (left side) and cross-pathway validation (right side) of the platform PBPK-QSP model originally developed for T-DM1. AD: Aggregate data; IPD: Individual patient data; mAb: monoclonal antibody; NHP: Non-human primates; PD: pharmacodynamics; PFS: progression-free survival; PK: pharmacokinetics; SAR408701: Tusamitamab ravtansine; (T-)Dxd: trastuzumab deruxtran;; : In vitro cell culture experiment; : In vivo mouse experiment; : In vivo NHP experiment; : Clinical trial data.

Article Snippet: For cross-pathway validation with SAR408701 (tusamitamab ravtansine), we thankfully acknowledge the provision of data from the ADC development at Sanofi, which are not publicly available, though.

Techniques: Biomarker Discovery, Drug discovery, In Vitro, Cell Culture, In Vivo